Cargando…
Safety And Tolerability Of Extended-Release Guaifenesin In Patients With Cough, Thickened Mucus And Chest Congestion Associated With Upper Respiratory Tract Infection
PURPOSE: An extended-release (ER) formulation of the expectorant guaifenesin has recently been launched in India for the treatment of productive cough accompanied by mucus (phlegm). Although the safety profile of ER guaifenesin marketed in the USA is well documented, there were limited safety data a...
Autores principales: | Tripathi, Sanjay, Nikhare, Ashish, Sharma, Gaurav, Shea, Tim, Albrecht, Helmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791405/ https://www.ncbi.nlm.nih.gov/pubmed/31632154 http://dx.doi.org/10.2147/DHPS.S222109 |
Ejemplares similares
-
Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections
por: Albrecht, Helmut H., et al.
Publicado: (2017) -
Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms
por: Albrecht, Helmut, et al.
Publicado: (2012) -
Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study
por: Septimus, Edward J., et al.
Publicado: (2017) -
Daily use of guaifenesin (Mucinex) in a patient with chronic bronchitis and pathologic mucus hypersecretion: A case report
por: Storms, William W., et al.
Publicado: (2018) -
Cough, Cold, and Congestion
por: Fitzpatrick, Desmond, et al.
Publicado: (2016)